Histopathologic changes of thymoma preoperatively treated with corticosteroids

Area of Science:

• Oncology
• Pathology
• Immunology

Background:

• Thymoma treatment often involves surgery, but preoperative strategies for advanced stages are less understood.
• Corticosteroids are explored for tumor size reduction, yet their precise impact on thymoma histology requires detailed examination.

Purpose of the Study:

• To investigate the histopathologic changes in thymoma after corticosteroid pretreatment.
• To assess the effectiveness of corticosteroids by evaluating MIB-1 and apoptotic indices.
• To explore potential histogenetic relationships between thymoma subtypes.

Main Methods:

• Histopathologic analysis of pretreatment biopsies and posttreatment surgical specimens from eleven thymoma cases.
• Immunohistochemical assessment for MIB-1 labeling (proliferation) and apoptotic cells.
• Classification of thymoma subtypes using the Muller-Hermelink system.

Main Results:

• Seven out of eleven tumors showed clinical size reduction after corticosteroid treatment.
• Histologic subtypes shifted: mixed thymomas became medullary, and cortical/predominantly cortical thymomas became epithelial-rich.
• Increased apoptotic indices (P = 0.001) and a trend towards decreased MIB-1 indices were observed.
• Three cases developed postoperative fungal infections.

Conclusions:

• Corticosteroid pretreatment can induce degenerative changes in thymoma epithelial cells and lymphocytes.
• A potential histogenetic link exists between medullary and mixed thymomas, and between cortical and predominantly cortical thymomas.
• Preoperative corticosteroid therapy may be beneficial for advanced thymoma but requires vigilance for postoperative infections.